11.955 USD
-0.05 (-0.46%)
Overall VTRS gets a fundamental rating of 4 out of 10. We evaluated VTRS against 192 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of VTRS while its profitability can be described as average. VTRS is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year VTRS was profitable.
VTRS had a positive operating cash flow in the past year.
In multiple years VTRS reported negative net income over the last 5 years.
In the past 5 years VTRS always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of -9.73%, VTRS is doing good in the industry, outperforming 67.19% of the companies in the same industry.
VTRS's Return On Equity of -24.26% is fine compared to the rest of the industry. VTRS outperforms 64.58% of its industry peers.
The Return On Invested Capital of VTRS (3.41%) is better than 80.73% of its industry peers.
VTRS had an Average Return On Invested Capital over the past 3 years of 4.05%. This is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROIC | 3.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
1.3 Margins
VTRS has a Operating Margin of 9.34%. This is amongst the best in the industry. VTRS outperforms 82.29% of its industry peers.
In the last couple of years the Operating Margin of VTRS has declined.
Looking at the Gross Margin, with a value of 39.36%, VTRS is in the better half of the industry, outperforming 60.94% of the companies in the same industry.
VTRS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% |
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VTRS is destroying value.
VTRS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, VTRS has more shares outstanding
The debt/assets ratio for VTRS has been reduced compared to a year ago.
2.2 Solvency
VTRS has an Altman-Z score of 0.93. This is a bad value and indicates that VTRS is not financially healthy and even has some risk of bankruptcy.
VTRS's Altman-Z score of 0.93 is in line compared to the rest of the industry. VTRS outperforms 51.04% of its industry peers.
VTRS has a debt to FCF ratio of 8.96. This is a slightly negative value and a sign of low solvency as VTRS would need 8.96 years to pay back of all of its debts.
VTRS has a Debt to FCF ratio of 8.96. This is in the better half of the industry: VTRS outperforms 79.69% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that VTRS is somewhat dependend on debt financing.
VTRS has a worse Debt to Equity ratio (0.82) than 71.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Altman-Z | 0.93 |
ROIC/WACC0.42
WACC8.05%
2.3 Liquidity
VTRS has a Current Ratio of 1.35. This is a normal value and indicates that VTRS is financially healthy and should not expect problems in meeting its short term obligations.
VTRS has a worse Current ratio (1.35) than 74.48% of its industry peers.
A Quick Ratio of 0.79 indicates that VTRS may have some problems paying its short term obligations.
The Quick ratio of VTRS (0.79) is worse than 82.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
VTRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.65%.
The Earnings Per Share has been decreasing by -9.73% on average over the past years.
The Revenue has decreased by -6.14% in the past year.
VTRS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.09% yearly.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
3.2 Future
The Earnings Per Share is expected to grow by 4.45% on average over the next years.
VTRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.49% yearly.
EPS Next Y-10.83%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue Next Year-4.74%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.59%
Revenue Next 5Y0.49%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 5.13, the valuation of VTRS can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 96.35% of the companies listed in the same industry.
VTRS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.61.
The Price/Forward Earnings ratio is 4.74, which indicates a rather cheap valuation of VTRS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 96.35% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.01. VTRS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.13 | ||
| Fwd PE | 4.74 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 95.83% of the companies listed in the same industry.
92.71% of the companies in the same industry are more expensive than VTRS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.54 | ||
| EV/EBITDA | 6.61 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
5. Dividend
5.1 Amount
VTRS has a Yearly Dividend Yield of 4.46%, which is a nice return.
VTRS's Dividend Yield is rather good when compared to the industry average which is at 0.45. VTRS pays more dividend than 96.88% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, VTRS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.46% |
5.2 History
VTRS has paid a dividend for at least 10 years, which is a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-15.34%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
NASDAQ:VTRS (12/23/2025, 12:12:48 PM)
11.955
-0.05 (-0.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners86.85%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change-0.14%
Market Cap13.77B
Revenue(TTM)14.12B
Net Income(TTM)-3.69B
Analysts71.76
Price Target12.38 (3.55%)
Short Float %2.29%
Short Ratio3.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.46% |
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)3.36%
PT rev (3m)10%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-1.81%
EPS NY rev (1m)1.34%
EPS NY rev (3m)1.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.3%
Revenue NY rev (1m)1.42%
Revenue NY rev (3m)1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.13 | ||
| Fwd PE | 4.74 | ||
| P/S | 0.97 | ||
| P/FCF | 8.54 | ||
| P/OCF | 6.94 | ||
| P/B | 0.9 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.61 |
EPS(TTM)2.33
EY19.49%
EPS(NY)2.52
Fwd EY21.09%
FCF(TTM)1.4
FCFY11.7%
OCF(TTM)1.72
OCFY14.4%
SpS12.26
BVpS13.21
TBVpS-6.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number26.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROCE | 4.32% | ||
| ROIC | 3.41% | ||
| ROICexc | 3.53% | ||
| ROICexgc | 14.83% | ||
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% | ||
| FCFM | 11.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 13.37% | ||
| Cap/Sales | 2.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.4% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 0.93 |
F-Score4
WACC8.05%
ROIC/WACC0.42
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-10.83%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-4.74%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.59%
Revenue Next 5Y0.49%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-5.05%
EBIT Next 3Y0.82%
EBIT Next 5Y1.31%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%
VIATRIS INC / VTRS FAQ
What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to VTRS.
Can you provide the valuation status for VIATRIS INC?
ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.
What is the profitability of VTRS stock?
VIATRIS INC (VTRS) has a profitability rating of 5 / 10.
Can you provide the financial health for VTRS stock?
The financial health rating of VIATRIS INC (VTRS) is 3 / 10.
Can you provide the expected EPS growth for VTRS stock?
The Earnings per Share (EPS) of VIATRIS INC (VTRS) is expected to decline by -10.83% in the next year.